A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure
NCT00950508 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 183
Last updated 2014-11-05
Summary
The aim of this study is to examine if high-volume plasma exchange has a positive effect on mortality in patients with acute liver failure.
Conditions
- Acute Liver Failure
Interventions
- PROCEDURE
-
High volume plasma exchange
3 high volume plasma exchanges over 3 days
- PROCEDURE
-
Standard medical treatment
Standard medical treatment
Sponsors & Collaborators
-
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Fin S Larsen, PhD,Dr.M.Sc · Rigshospitalet, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-06-30
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- Denmark
- Finland
- United Kingdom
Study Locations
More Related Trials
-
High-volume Versus Standard Volume Plasma Exchange in Patients With Acute Liver Failure With Cerebral Edema
NCT06515145 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.
NCT04311489 ·Status: TERMINATED ·Phase: PHASE2
-
Standard Volume vs. High Volume Plasma Exchange in Pediatric Acute Liver Failure
NCT06831643 ·Status: RECRUITING ·Phase: NA
-
The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients
NCT05030571 ·Status: RECRUITING ·Phase: NA
-
To Evaluate the Safety and Efficacy of Preemptive Administration of Continuous Renal Replacement Therapy in Patients With Acute Liver Failure With Cerebral Edema
NCT04991259 ·Status: UNKNOWN ·Phase: NA
-
Patients' Outcome With Severe or Fulminant Hepatic Insufficiency, Hospitalized in the Public Hospitals of Paris
NCT04658407 ·Status: UNKNOWN
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
Thromboelastography Guides a Multicentre Cluster Controlled Study of Plasma Exchange for Hepatitis B Associated Acute-on-chronic Liver Failure
NCT04747106 ·Status: UNKNOWN ·Phase: NA
-
Effects on Plasma Exchange on Functional Capacity of Serum Albumin, Circulatory Dysfunction, Renal and Cerebral Function in Cirrhotic Patients With "Acute-on-chronic Liver Failure"
NCT01201720 ·Status: COMPLETED ·Phase: NA
-
Plasma Exchange in Acute on Chronic Liver Failure
NCT04051437 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function
NCT06355726 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Hepatocyte Transplantation for Liver Cirrhosis
NCT04806581 ·Status: UNKNOWN ·Phase: PHASE1
-
Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy
NCT05124041 ·Status: COMPLETED ·Phase: NA
-
Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units
NCT01079091 ·Status: TERMINATED ·Phase: NA
-
Evaluate Safety and Efficacy of Autologous Bone Marrow-derived Endothelial Progenitor Cells in Advanced Liver Cirrhosis
NCT01333228 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination of DPMAS and Low Volume PE for Patients With HBV Related ACLF
NCT04597164 ·Status: RECRUITING
-
Cytokine Adsorption in Acute-on-chronic Liver Failure
NCT05019352 ·Status: UNKNOWN ·Phase: NA
-
Hepa Wash Treatment of Patients With Hepatic Dysfunction in Intensive Care Units
NCT01079104 ·Status: TERMINATED ·Phase: NA
-
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
NCT07178366 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure
NCT03084198 ·Status: UNKNOWN ·Phase: NA
-
The Plasma Diafiltration Therapy of Hepatic Failure
NCT03560414 ·Status: UNKNOWN ·Phase: NA
-
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312 ·Status: COMPLETED
-
Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
NCT01966419 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis
NCT00992888 ·Status: COMPLETED ·Phase: NA
-
Hepatocyte Transplantation as a Life Support Bridge
NCT00282542 ·Status: WITHDRAWN ·Phase: NA